NVLT looks ready for a big bounce here. Down 90% last week due to failed FDA trail. They still have 2 drugs in the pipeline - Breast cancer and hepatitis C trials. Extremely oversold here. Looking for a bounce back to .40 minimum IMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.